CryoPort (NASDAQ:CYRX) was upgraded by BidaskClub from a “buy” rating to a “strong-buy” rating in a note issued to investors on Wednesday.
Several other equities analysts also recently commented on the company. Roth Capital started coverage on CryoPort in a research report on Thursday, November 30th. They set a “buy” rating and a $12.50 target price for the company. Needham & Company LLC reiterated a “buy” rating and issued a $11.00 price objective (up previously from $10.00) on shares of CryoPort in a research report on Thursday, March 8th. One research analyst has rated the stock with a hold rating, four have issued a buy rating and one has given a strong buy rating to the company. The company has a consensus rating of “Buy” and an average target price of $33.70.
CYRX stock opened at $10.19 on Wednesday. CryoPort has a 52-week low of $1.96 and a 52-week high of $10.40.
CryoPort (NASDAQ:CYRX) last posted its earnings results on Tuesday, March 6th. The consumer goods maker reported ($0.09) EPS for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.07) by ($0.02). The company had revenue of $3.33 million for the quarter, compared to the consensus estimate of $3.37 million. CryoPort had a negative return on equity of 47.36% and a negative net margin of 66.09%. The business’s revenue was up 49.5% on a year-over-year basis. equities analysts predict that CryoPort will post -0.29 EPS for the current year.
In other CryoPort news, CEO Jerrell Shelton sold 29,257 shares of CryoPort stock in a transaction on Tuesday, March 13th. The stock was sold at an average price of $9.83, for a total value of $287,596.31. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Insiders own 9.00% of the company’s stock.
A number of institutional investors and hedge funds have recently modified their holdings of the business. Pier Capital LLC bought a new position in CryoPort in the 4th quarter valued at $2,916,000. Millennium Management LLC raised its position in CryoPort by 71.5% in the 4th quarter. Millennium Management LLC now owns 142,331 shares of the consumer goods maker’s stock valued at $1,223,000 after purchasing an additional 59,331 shares during the last quarter. Goldman Sachs Group Inc. bought a new position in CryoPort in the 4th quarter valued at $155,000. BlueCrest Capital Management Ltd bought a new position in CryoPort in the 4th quarter valued at $432,000. Finally, Allianz Asset Management GmbH raised its position in CryoPort by 240.5% in the 4th quarter. Allianz Asset Management GmbH now owns 387,099 shares of the consumer goods maker’s stock valued at $3,325,000 after purchasing an additional 273,426 shares during the last quarter. Hedge funds and other institutional investors own 23.71% of the company’s stock.
Cryoport, Inc (Cryoport) is a provider of cryogenic logistics solutions to the life sciences industry through its purpose-built packaging, information technology and specialized cold chain logistics expertise. The Company provides logistics solutions for biologic materials, such as immunotherapies, stem cells, chimeric antigen receptors (CAR)-T cells, and reproductive cells for clients.
Receive News & Ratings for CryoPort Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CryoPort and related companies with MarketBeat.com's FREE daily email newsletter.